TokenPost·
Eagle Pharmaceuticals Extends Stockholder Rights Plan Through 2027
The plan’s rights may be triggered at 10% beneficial ownership, or 15% for covered passive institutional investors.
More news
- Crypto BriefingTrump says he will review record $6.3 billion Binance hack
- TokenPostFormer Richmond Fed President Lacker Says Fed Lacks Inflation Urgency
- UnchainedZooko and Sean Bowe Back Plan to Pull 50,000 ZEC From Zcash’s Grants Treasury
- TokenPostOKX Publishes Its 48th Consecutive Proof-of-Reserves Report
- Crypto BriefingWall Street analysts call the Binance hack selloff a buying opportunity for crypto stocks
- TokenPostRussia Drafts 24/7 Data Access Rules for Regulated Crypto Firms